4th Quarter - Termination — ACHAOGEN for ACHAOGEN (2018)

Firm

ACHAOGEN

Client

ACHAOGEN

Income

—

Expenses

$20,000

Expense method

A: Lobbying Disclosure Act definitions

Terminated

Nov 1, 2018

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

REVAMP- antibiotic pull incentive DISARM- antibiotic reimbursement Hospital reimbursement ( NTAP and DRG) BARDA funding PAHPA reauthorization as it pertains to antibiotics

Lobbyist	Covered position, as disclosed
STEPHANIE DYSON	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); White House Office; Health & Human Services, Dept of (HHS)

Health Issues HCR

Public Health and Bio threat issues as it pertains to antibiotics Hospital reimbursement for antibiotics ( NTAP and DRG) BARDA funding and other private/public funding issues

Lobbyist	Covered position, as disclosed
STEPHANIE DYSON	—

Contacted: White House Office; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.